News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Handpicked By Ex-CEO, Takeda Pharmaceutical Co. Ltd. (TKPYY)'s New Leader Vows To Remain Japanese-Based, Will Attempt To Get Company Out Of Slump



8/12/2014 6:44:06 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

The inauguration in June of Christophe Weber as president of Takeda Pharmaceutical Co. invited opposition from a group of its former executives and members of its founding family, but the Frenchman says Takeda will remain “Japanese-based” under his leadership.

“I think there is sometimes this fear that, because I’m a foreigner, (Takeda may) lose its roots in Japan. Not at all,” the 47-year-old Weber said in a recent interview with The Japan Times. “We’ll remain a Japanese-based company.”

A globalizing Japanese company seeking to enlist the management expertise of foreign nationals is no longer uncommon, especially after Nissan Motor Co. CEO Carlos Ghosn led the major automaker out of a slump.

Help employers find you! Check out all the jobs and post your resume.

Read at Japan Times


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES